30 years on, AstraZeneca sees healthy future

This year marks the 30th anniversary of biopharmaceutical company AstraZeneca's entrance into China.

"China's medical and healthcare industry has experienced booming development over the past three decades," said Leon Wang, executive vice-president international and China president of AstraZeneca, at the anniversary celebration held on Friday in Wuxi, Jiangsu province, where the company started its Chinese business 30 years ago.

Wang said that AstraZeneca is honored to be a witness to and beneficiary of the process.

The biopharmaceutical company's first decade in China was dedicated to bringing innovative medicines to the country, the second decade increased investment in manufacturing and the third focused on the continuous investment and construction of a health innovation ecosystem, Wang said.